US-based cardiac technology company HeartBeam has entered a deal with Evolve Manufacturing Technologies to develop the AIMIGo 3D vector electrocardiogram (VECG) recording device for remote heart attack detection.

The new credit card-sized AIMIGo 3D VECG device offers a 12-lead ECG readout.

Under the deal terms, HeartBeam will use the manufacturing and packaging knowledge of Evolve to commercialise the new device with early market testing expected in the second quarter of next year.

US Food and Drug Administration (FDA) clearance for the device is expected early next year.

HeartBeam developed the AIMIGo device as a personal, portable and simple-to-use heart attack detection system that can be used by patients anytime and anywhere.

The device is intended to support patients and clinicians in determining if symptoms might be the result of a heart attack.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

The solution comprises a credit card-sized, reusable, 3D vector ECG recording device and cloud-based software that transmits vital data to clinicians in real-time outside of a medical setting.

HeartBeam CEO and founder Branislav Vajdic said: “Evolve has deep medical device manufacturing expertise and a strong reputation in the industry for delivering consistent product quality and customer care rarely found in medical contract manufacturers.

“Evolve’s dedicated customer teams use Design for Excellence (DFX) methodologies, and state-of-the-art, end-to-end quality processes, plus world-class materials suppliers to ensure consistent and high-quality products.

“We have now begun technology transfer from Triple Ring Technologies to Evolve as they develop and obtain experience with our product in preparation for manufacturing.”

Evolve offers end-to-end contract manufacturing services for medical device and life sciences instrument firms.

It also provides medical device makers with ISO-certified turnkey contract manufacturing.